Breaking the Negative Symptom Barrier: A Novel Neuromodulation Strategy Using HD-tDCS Primed iTBS in Schizophrenia.

BACKGROUND: Negative symptoms in schizophrenia are associated with long-term disability and poor functional outcomes. These symptoms remain inadequately addressed by current pharmacological and psychosocial interventions. Neuromodulation strategies,…

Preview only. Read the full abstract at the source